Novel adverse events of bevacizumab in the US FDA adverse event reporting system database: a disproportionality analysis (Q33401326)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel adverse events of bevacizumab in the US FDA adverse event reporting system database: a disproportionality analysis |
scientific article |
Statements
1 reference
Novel adverse events of bevacizumab in the US FDA adverse event reporting system database: a disproportionality analysis (English)
1 reference
Behrooz K Shamloo
1 reference
Pankdeep Chhabra
1 reference
Andrew N Freedman
1 reference
Arnold Potosky
1 reference
Jennifer Malin
1 reference
Sheila Weiss Smith
1 reference
1 June 2012
1 reference
1 reference
35
1 reference
507-518
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference